Cuu Long Pharmaceutical JSC
VN:DCL
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
22 350
30 400
|
| Price Target |
|
We'll email you a reminder when the closing price reaches VND.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Cuu Long Pharmaceutical JSC
Accounts Receivables
Cuu Long Pharmaceutical JSC
Accounts Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accounts Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
C
|
Cuu Long Pharmaceutical JSC
VN:DCL
|
Accounts Receivables
₫266.5B
|
CAGR 3-Years
18%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
|
H
|
HaTay Pharmaceutical JSC
VN:DHT
|
Accounts Receivables
₫110.6B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
7%
|
|
|
I
|
Imexpharm Corp
VN:IMP
|
Accounts Receivables
₫357.3B
|
CAGR 3-Years
14%
|
CAGR 5-Years
15%
|
CAGR 10-Years
8%
|
|
|
D
|
Domesco Medical Import Export Joint Stock Corp
VN:DMC
|
Accounts Receivables
₫706.9B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
1%
|
CAGR 10-Years
9%
|
|
|
D
|
Dhg Pharmaceutical Joint-Stock Co
VN:DHG
|
Accounts Receivables
₫446.4B
|
CAGR 3-Years
19%
|
CAGR 5-Years
2%
|
CAGR 10-Years
0%
|
|
|
T
|
Traphaco JSC
VN:TRA
|
Accounts Receivables
₫257.7B
|
CAGR 3-Years
13%
|
CAGR 5-Years
13%
|
CAGR 10-Years
2%
|
|
Cuu Long Pharmaceutical JSC
Glance View
Cuu Long Pharmaceutical JSC engages in the manufacture, sale, import, and export of pharmaceutical, capsules, and medical instruments. The company is headquartered in Vinh Long, Vinh Long and currently employs 934 full-time employees. The company went IPO on 2008-09-17. The firm manufactures, markets and distributes pharmaceutical drugs and capsules, as well as medical equipment and supplies. The company is also involved in the manufacture and trading of functional food, cosmetic products, chemicals and other materials for pharmaceutical production. Other activities include the manufacture of specialized packagings for drugs and medical products, as well as the cultivation of traditional herbs.
See Also
What is Cuu Long Pharmaceutical JSC's Accounts Receivables?
Accounts Receivables
266.5B
VND
Based on the financial report for Dec 31, 2023, Cuu Long Pharmaceutical JSC's Accounts Receivables amounts to 266.5B VND.
What is Cuu Long Pharmaceutical JSC's Accounts Receivables growth rate?
Accounts Receivables CAGR 5Y
5%
Over the last year, the Accounts Receivables growth was 37%. The average annual Accounts Receivables growth rates for Cuu Long Pharmaceutical JSC have been 18% over the past three years , 5% over the past five years .
You don't have any saved screeners yet
